jw-pharma hair loss
Scope
Date
~
-
Bio & Pharma
JW Pharma receives 1st overseas patent for its hair loss treatment
JW Pharmaceutical, a drug company based in South Korea, has received its first patent for a hair loss treatment that is currently in development. Th...
Mar 27, 2023 (Gmt+09:00)
-
Bio & Pharma
OliX's hair loss treatment candidate approved for clinical trial in Australia
South Korea's OliX Pharmaceuticals has received approval from Australia's Human Research Ethics Committees (HREC) to plan a phase 1 clinical trial o...
Mar 10, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma to develop mRNA flu vaccine with Canadian pharma
South Korea's GC Biopharma Corp. announced on Thursday that it will start developing a flu vaccine based on messenger ribonucleic acid (mRNA).The dr...
Mar 09, 2023 (Gmt+09:00)
-
Pension funds
S.Korea's NPS likely to log 8.2% loss for 2022, record-low return
South Korea’s National Pension Service (NPS) is expected to post a negative return of 8.2% for 2022, according to its preliminary report on Th...
Mar 02, 2023 (Gmt+09:00)
-
Economy
S.Korea’s exports drop for 5th straight month in Feb on plunging chip sales
South Korea’s exports shrank 7.5% year over year in February on a plunge in shipments of its mainstay export item semiconductors amid the glob...
Mar 02, 2023 (Gmt+09:00)
-
Pension funds
S.Korea's GEPS logs 10.2% return on alternative assets in 2022
South Korea’s Government Employees Pension Service (GEPS) had a 4.4% loss on investment last year, seeing its assets under management (AUM) dr...
Mar 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma's Fexuclue safe to use with aspirin: Clinical trials
Daewoong Pharmaceutical Co., a leading South Korean pharmaceutical company, has announced the successful completion of phase 1 clinical trials for...
Feb 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Novel medicines poised to be Korea’s next mainstay export
South Korea, a major global generic and biosimilar medicine producer with leading names such as Samsung Biologics Co. and Celltrion Inc., has rapidl...
Feb 27, 2023 (Gmt+09:00)
-
Sovereign wealth funds
Korean sovereign wealth fund KIC logs record loss in 2022
Sovereign wealth fund Korea Investment Corporation (KIC) posted the largest annual loss last year since its inception in 2005, according to its 20...
Feb 15, 2023 (Gmt+09:00)
-
Shareholder activism
Activist fund KCGI to sell Osstem stake to UCK, MBK Partners
Korea Corporate Governance Improvement Fund (KCGI), one of the country’s most aggressive shareholder activists, plans to sell its stake in Oss...
Feb 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma wins permission from Singapore for Nabota
South Korea's drug development company Daewoong Pharmaceutical said on Thursday that it received on Jan. 20 product approval for its botulinum toxin...
Feb 10, 2023 (Gmt+09:00)
-
Earnings
Fintech firm Kakao Pay logs first yearly net profit in 2022
Kakao Pay Corp., the mobile payment service unit of South Korean tech giant Kakao Corp., posted a net profit last year for the first time since its ...
Feb 08, 2023 (Gmt+09:00)
-
Earnings
Korea refiners swing to Q4 loss amid windfall tax calls
South Korean refiners such as SK Innovation Co. and S-Oil Corp. are estimated to incur a combined loss of over 1 trillion won ($800 million) in the ...
Feb 07, 2023 (Gmt+09:00)
-
Earnings
SKC eyes M&As in semiconductor, rechargeable battery materials
SKC Inc., a South Korean chemical materials company under SK Group, is seeking to buy semiconductor and rechargeable battery materials companies in ...
Feb 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma's botulinum toxin Nabota proves long-lasting effect
Daewoong Pharmaceutical said on Friday that a high-dose administration of botulinum toxin Nabota (US brand name: Jeuveau) to patients with frown wri...
Feb 03, 2023 (Gmt+09:00)
-
Earnings
SK Hynix to halve investment after posting first quarterly loss in decade
SK Hynix Inc., the world’s second-largest memory chipmaker, said on Wednesday it will significantly slash its investment for this year after p...
Feb 01, 2023 (Gmt+09:00)
-
Electric vehicles
LG Elec eyes profit from EV powertrain, car lighting biz
LG Electronics Inc., the world’s leading home appliance maker, aims to take profit from the electric vehicle powertrain and car lighting units...
Jan 31, 2023 (Gmt+09:00)
-
Pension funds
NPS underperforms global peers by returns for Q1-Q3 2022
South Korea's National Pension Service (NPS), the world's third-largest pension fund, ranked 10th out of the global 42 state-owned investors by rate...
Jan 31, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma to put AI into new drug ingredient development
South Korea's drug developer JW Pharmaceutical is expanding the scope of its artificial intelligence (AI) uses from new drug research to the develop...
Jan 30, 2023 (Gmt+09:00)
-
Korean chipmakers
Samsung considers chip output cut as first-quarter loss looms large
Samsung Electronics Co., the world’s largest memory chipmaker, is considering slashing its semiconductor production as the company is heading ...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma's botulinum toxin Nabota wins approval from Australia
Daewoong Pharmaceutical said on Wednesday that its botulinum toxin formulation Nabota (overseas brand name: Nuceiva) won approval in Australia on Ja...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
CMG Pharma acquires animal nutrition company ING Medix
CMG Pharmaceutical, a subsidiary of South Korea's CHA Biotech, said on Monday that it is moving into the pet nutrition supplement market by acquirin...
Jan 17, 2023 (Gmt+09:00)
-
ECM/DCM
S.Korean brokerage lowers stock forecast for S-Oil over poor prospects
South Korea's Eugene Investment & Securities on Monday cut S-Oil Corp.'s target share price from 140,000 won ($113.5) to 133,000 won due to a lo...
Jan 16, 2023 (Gmt+09:00)
-
Alternative investments
S.Korea's DLS incurring losses due to stock slump exceed $800 billion
South Korea's derivatives-linked securities that entered the knock-in or loss period due to stock slumps at home and abroad exceeded 1 trillion won ...
Jan 09, 2023 (Gmt+09:00)
-
Airlines
Korean LCCs cancel China-bound flights due to COVID-19
Toughened COVID-19 testing requirements on Chinese travelers will likely dent hopes for South Korea's low-cost airlines to recover from three years ...
Jan 04, 2023 (Gmt+09:00)
-
Pension funds
Korea’s NPS to be in red in 2022 with 5.3% loss in Jan-Oct
South Korea’s National Pension Service (NPS), the world’s third-largest such fund, is poised to report an annual loss in 2022 for the fi...
Jan 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma, Neurolive to jointly develop new antidepressant drug
South Korea's drug company Daewoong Pharmaceutical said on Wednesday that it has signed an agreement with biopharmaceutical venture Neurorive to joi...
Dec 28, 2022 (Gmt+09:00)
-
Electronics
LG Innotek to unveil precision smartphone camera module
South Korea's LG Innotek said on Thursday it will unveil its high-magnification optical camera module with continuous zoom next month at CES 2023, t...
Dec 23, 2022 (Gmt+09:00)
-
Bio & Pharma
JW Pharma applies for phase 3 trial in Taiwan for gout treatment
JW Pharmaceutical announced through its disclosure on Monday that it had applied last Friday for a phase 3 trial for Epaminurad, a gout treatment, w...
Dec 19, 2022 (Gmt+09:00)
-
Supply chain
Korea’s industrial losses balloon to $1.2 bn as truckers continue strike
South Korea’s manufacturing sector faces ballooning losses across industries as the trucker strike entered its eighth day on Thursday, disrupt...
Dec 01, 2022 (Gmt+09:00)
Latest News
- 1 Coupang bids for Korean luxury market dominance with Farfetch
- 2 Hyundai Rotem set to finalize $6 bn K2 tank order from Poland
- 3 Lee Jae-myung to meet with top business leaders this week ahead of G7 summit
- 4 Korea to allow non-profits to buy bad consumer loans
- 5 LG to drive future growth in emerging markets with battery prowess